The state of Connecticut is granting three licenses for the production of medical marijuana. PharmaFarm is developing a concentrated and whole plant flower medication (and related products). The Company expects to capture one-third of projected total Connecticut market share, which will grow from 1,200 registered patients in October 2013 to 3,600 patients in summer 2014 when the medication is available to the patient marketplace.